Clinical Trial Update: Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing sequential therapy with entecavir followed by Pegasys versus Pegasys alone in HBeAg-negative chronic hepatitis B. The results s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatitis B, Chronic | Phase 4 | Status: UNKNOWN